Point72 Middle East Fze Halozyme Therapeutics, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$33.32 - $42.1 $306,310 - $387,025
9,193 Added 20.25%
54,592 $2.02 Million
Q3 2023

Nov 14, 2023
BUY
$36.46 - $44.03 $1.5 Million - $1.81 Million
41,019 Added 936.51%
45,399 $1.73 Million
Q2 2023

Aug 14, 2023
BUY
$30.28 - $38.74 $132,626 - $169,681
4,380 New
4,380 $157,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email